Literature DB >> 30855513

Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report: Erratum.

.   

Abstract

Entities:  

Year:  2019        PMID: 30855513      PMCID: PMC6417611          DOI: 10.1097/MD.0000000000014869

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


× No keyword cloud information.
In the article, “Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report”,[ which appeared in Volume 96, Issue 51 of Medicine, “PDMSCs hydrogel (cell number: 1 × 10^6/cells/cm2)” should be written as “PDMSCs hydrogel (cell number: 1 × 10^6/cells/ml).”
  1 in total

Review 1.  Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report.

Authors:  Xiangxia Zeng; Yunliang Tang; Kaixiang Hu; Wang Jiao; Liu Ying; Lingyan Zhu; Jianying Liu; Jixiong Xu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.